Skip to main content
. 2022 Jun 3;11:327–345. doi: 10.1016/j.xjon.2022.05.017

Table E3.

Characteristics of lobectomy patients with or without 30-day readmission following lobectomy and multivariable logistic regression for 30-day readmission

30-day readmission
Multivariable logistic regression
Covariate n (%) P value Odds ratio (95% CI) P value
Sex
 Female 37 (7.8) .92 Ref
 Male 27 (7.9) 0.91 (0.52-1.62) .76
Age, y
 <70 32 (7.0) .31 Ref
 ≥70 32 (8.9) 1.26 (0.73-2.19) .41
Race
 White 57 (8.1) .52 Ref
 Not White 7 (6.3) 0.83 (0.35-1.93) .66
BMI
 <25 21 (7.7) .55 Ref
 25-29.9 26 (9.1) 1.23 (0.65-2.33) .27
 ≥30 17 (6.6) 0.82 (0.40-1.70) .34
Laterality
 Left 19 (6.2) .17 Ref
 Right 45 (8.8) 1.49 (0.83-2.67) .18
Lobe
 Upper 44 (8.9) .01 Ref
 Middle 5 (6.8) 0.65 (0.23-1.80) .65
 Lower 15 (6.0) 0.67 (0.36-1.26) .63
Active smoker
 No 53 (8.5) .19 Ref
 Yes 11 (5.6) 0.64 (0.32-1.30) .22
Preoperative chemotherapy
 No 57 (7.5) .08 Ref
 Yes 7 (12.5) 1.00 (0.36-2.80) 1.00
Previous radiation therapy
 No 57 (7.4) .03 Ref
 Yes 7 (12.5) 2.32 (0.83-6.50) .11
Minimally invasive vs open
 Minimally invasive 51 (7.3) .20 Ref
 Open 13 (10.7) 1.15 (0.54-2.46) .72
FEV1 % predicted
 >80 40 (7.6) .03 Ref
 ≤80 22 (8.1) 1.07 (0.60-1.89) .97
 Missing 2 (8.7) 1.09 (0.24-5.05) .94
Asthma
 No 53 (7.9) .86 Ref
 Yes 11 (7.5) 1.04 (0.51-2.11) .91
Past pneumonia
 No 54 (7.8) .99 Ref
 Yes 10 (7.9) 0.97 (0.47-2.01) .93
Diabetes
 No 51 (7.5) .43 Ref
 Yes 13 (9.5) 1.56 (0.77-3.17) .22
Hypertension
 No 28 (8.9) .37 Ref
 Yes 36 (7.2) 0.71 (0.40-1.27) .25
Coronary artery disease
 No 52 (7.5) .46 Ref
 Yes 12 (9.4) 1.16 (0.56-2.42) .68
Hiatal hernia
 No 31 (7.7) .87 Ref
 Yes 33 (8.0) 0.96 (0.56, 1.65) .88
GERD
 No 35 (7.0) .27 Ref
 Yes 29 (9.1) 1.73 (0.91-3.27) .10
Preoperative acid-suppressive therapy
 No 43 (7.8) .98 Ref
 Yes 21 (7.9) 1.46 (0.74-2.88) .27
Intraoperative RBCs
 No 60 (7.5) .04 Ref
 Yes 4 (21.1) 2.44 (0.69-8.63) .17

CI, Confidence interval; Ref, reference; BMI, body mass index; FEV1, forced expiratory volume in 1 second; GERD, gastroesophageal reflux disease; RBCs, red blood cells.